# A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

> **NCT00377234** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 356 (actual)

## Conditions studied

- Post Menopausal Osteoporosis

## Interventions

- **DRUG:** Risedronate
- **DRUG:** ibandronate [Bonviva/Boniva]

## Key facts

- **NCT ID:** NCT00377234
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2016-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377234, "A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00377234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*